5-Methoxy-1H-indole-3-carbaldehyde
Suppliers
Names
[ CAS No. ]:
10601-19-1
[ Name ]:
5-Methoxy-1H-indole-3-carbaldehyde
[Synonym ]:
5-Methoxy-1H-indole-3-carbaldehyde
1H-Indole-3-carboxaldehyde, 5-methoxy-
5-METHOXY-3-INDOLECARBALDEHYDE
5-methoxyindole-3-formaldehyde
3-Formyl-5-methoxyindole
5-Methoxyindole-3-carboxyaldehyde
5-methoxy-1H-indole-3-carboxaIdehyde
5-METHOXYINDOLYL-3-ALDEHYDE
5-methoxyindole-3-carbaldehyde
5-methoxy-1H-indole-3-carboxaldehyde
5-methoxy-1H-indole-3-carbaIdehyde
EINECS 234-220-5
5-METHOXY-3-FORMYLINDOLE
5-METHOXY-3-INDOLECARBOXALDEHYDE
MFCD00005623
5-Methoxyindole-3-carboxaldehyde
5-METHOXYINDOLE-3-ALDEHYDE
Chemical & Physical Properties
[ Density]:
1.3±0.1 g/cm3
[ Boiling Point ]:
375.2±22.0 °C at 760 mmHg
[ Melting Point ]:
179-183 °C(lit.)
[ Molecular Formula ]:
C10H9NO2
[ Molecular Weight ]:
175.184
[ Flash Point ]:
180.7±22.3 °C
[ Exact Mass ]:
175.063324
[ PSA ]:
42.09000
[ LogP ]:
1.60
[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C
[ Index of Refraction ]:
1.680
[ Water Solubility ]:
insoluble
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H315-H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2933990090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2933990090
[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
J. Med. Chem. 54 , 5320, (2011)
Tryptophan catabolism mediated by indoleamine 2,3-dioxygenase (IDO) is an important mechanism of peripheral immune tolerance contributing to tumoral immune resistance. IDO inhibition is thus an active...
Eur. J. Med. Chem. 45 , 2307, (2010)
Synthesis and antimicrobial activity of cholic acid analogues 4a-t are reported. The synthesis of 4a-t was accomplished from ethylcholate 2. The hydrazone moiety was introduced via coupling of the cho...
Invest. New Drugs 28 , 291, (2010)
A crucial event in prostate cancer progression is the transition from a hormone-sensitive to a lethal castration-refractory disease state. The antagonist-to-agonist conversion due to mutation in AR is...